Actualizado 03/05/2011 10:03
- Comunicado -

ProFibrix Secures Funding for Progression of Lead Product Into Late Stage Clinical Development and Announces Management

CONTACT: For further enquiries: Jan Ohrstrom, MD, CEO, ProFibrix,+1-206-9105-404, +31-63-1774-620, j.ohrstrom@profibrix.com. Hans Herklots,Principal, Capricorn One, +41-79-598-7149, capricorn1@bluewin.ch

Contenido patrocinado